HOME
  • About Shionogi
    • About Shionogi

        About

        • About
        • Company Profile
        • SHIONOGI Journal
        • BRAND STATEMENT
        • SHIONOGI Infectious Disease Weeks
          • Message from Top Management
          • Philosophy
          • Business Strategy
          • Business Activities
          • Shionogi's Strength
          • Group Companies
          • History
          • Policies
          • Compliance
          • Compliance Promotion Structure and Initiatives
          • Commitment to Tax Compliance
          • Ensuring High Ethical Standards and Transparency in Business Activities
          • Corporate Governance
          • Basic Views and Guidelines on Corporate Governance
          • Corporate Governance System
          • Board
          • Shareholdings
  • Sustainability
    • Sustainability

        Sustainability

        • Sustainability
        • Material Issues
          • Environment
          • Policy / Approach
          • Environmental Topics
          • Initiatives for Each Theme
          • Information Disclosure / Data
          • Society
          • Ensuring quality and safety in products and services
          • Attractive workplace
          • Respect Human Rights
          • Supply Chain Management
          • Social contribution activities
          • Governance
          • Corporate Governance
          • Risk Management
          • Compliance
          • Address the problem of antimicrobial resistance (AMR)
          • Our promise
          • Background of addressing the problem of antimicrobial resistance (AMR)
          • Long-term commitment to improving R&D to provide novel treatments for infectious diseases
          • Combating challenge of AMR
          • AMR
          • Shionogi AMR Position Paper
          • Access to healthcare
          • Developing innovative therapies to address unmet needs
          • Promote proper use of medicines
          • Improving affordability for patients in need
          • Improving access to healthcare services in developing countries
          • Stakeholder Engagement
          • Engagement with shareholders and investors
          • Engagement with customers
          • Engagement with employees
          • Engagement with society
          • Annual Report / Integrated Report / Environment Report
          • Data
          • External evaluation
          • About United Nations Global Compact
  • Innovation
    • Innovation

        Innovation

        • Innovation
        • Partnering
        • Pipeline
        • IP Strategy
        • Wastewater-based Epidemiology Surveillance Service
          • R&D
          • Overview of R&D
          • Drug discovery
          • Clinical Development
          • Digital therapy
          • Investigator-Initiated Research
          • Open Innovation
  • News
  • SPmenu
    • SPmenu
        • About
        • Company Profile
        • SHIONOGI Journal
        • BRAND STATEMENT
        • SHIONOGI Infectious Disease Weeks
          • Message from Top Management
          • Philosophy
          • Business Strategy
          • Business Activities
          • Shionogi's Strength
          • Group Companies
          • History
          • Policies
          • Compliance
          • SHIONOGI Group Compliance Policy
          • Compliance Promotion Structure and Initiatives
          • Commitment to Tax Compliance
          • Ensuring High Ethical Standards and Transparency in Business Activities
          • Corporate Governance
          • Basic Views and Guidelines on Corporate Governance
          • Corporate Governance System
          • Board
          • Shareholdings
        • Sustainability
        • Material Issues
          • Environment
          • Policy / Approach
          • Environmental Topics
          • Initiatives for Each Theme
          • Information Disclosure / Data
          • Society
          • Ensuring quality and safety in products and services
          • Attractive workplace
          • Respect Human Rights
          • Supply Chain Management
          • Social contribution activities
          • Governance
          • Corporate Governance
          • Risk Management
          • Compliance
          • Address the problem of antimicrobial resistance (AMR)
          • Our promise
          • Background of addressing the problem of antimicrobial resistance (AMR)
          • Long-term commitment to improving R&D to provide novel treatments for infectious diseases
          • Combating challenge of AMR
          • AMR
          • Shionogi AMR Position Paper
          • Access to healthcare
          • Developing innovative therapies to address unmet needs
          • Promote proper use of medicines
          • Improving affordability for patients in need
          • Improving access to healthcare services in developing countries
          • Stakeholder Engagement
          • Engagement with shareholders and investors
          • Engagement with customers
          • Engagement with employees
          • Engagement with society
          • Annual Report / Integrated Report / Environment Report
          • Data
          • External evaluation
          • About United Nations Global Compact
        • Innovation
        • Partnering
        • Pipeline
        • IP Strategy
        • Wastewater-based Epidemiology Surveillance Service
          • R&D
          • Overview of R&D
          • Drug discovery
          • Clinical Development
          • Digital therapy
          • Investigator-Initiated Research
          • Open Innovation
        News
  • Investors
  • Contact Us
  • Careers
English
Worldwide
  1. HOME
  2. About Shionogi
  3. Policies

Policies

Policies

 

In SHIONOGI Group, “Policies” are basic concepts that should be observed and practiced by our organization, officers, and employees from the perspective of social responsibility and corporate governance in order to embody our Heritage (The Company Policy of SHIONOGI). In addition, “Policies” are established by resolution of the Board of Directors.

 

  • SHIONOGI Group Enterprise Risk Management Policy
  • SHIONOGI Group Anti-Corruption/Anti-bribery Policy
  • SHIONOGI Group Global Health Access Policy Statement
  • SHIONOGI Group Global Privacy Policy
  • SHIONOGI Group Global Development Policy
  • SHIONOGI Group Clinical Trial Data Transparency Policy
  • SHIONOGI Group Publication Policy
  • SHIONOGI Group Managed Access Program Policy
  • SHIONOGI Group EHS Policy
  • SHIONOGI Group EHS Code of Conduct
  • SHIONOGI Group Health and Productivity Management Policy
  • SHIONOGI Group Procurement Policy
  • SHIONOGI Group Business Partner Code of Conduct
  • SHIONOGI Group Quality Policy
  • SHIONOGI Group Tax Policy
  • SHIONOGI Group Drug Safety Policy
  • SHIONOGI Group Intellectual Property Policy
  • SHIONOGI Group Human Rights Policy
  • SHIONOGI Group Policy in the fight against doping
  • Shionogi Disclosure Policy

 

※ “Policies” bearing the name "SHIONOGI Group" apply to all group companies.

 

  • About Shionogi
  • Sustainability
  • Innovation
  • News
  • Investors
  • ID Weeks Page
  • Terms of Service
  • Sitemap
  • Personal Information
Copyright (C) Shionogi & Co., Ltd. All Rights reserved.